Chiesi has published an article showcasing support towards EJP RD’s RDR Challenges Call.
The innovative “Rare Diseases Research (RDR) Challenges” call aims at facilitate and fund collaboration between industry, academia, SMEs, and patient organizations to solve specific research challenges in rare diseases.
“As B-Corp certified pharmaceutical company, Chiesi invests in multi-stakeholder collaboration as a crucial pillar of its commitment to society and the environment. One of the most recent examples is its participation in the Rare Diseases Research (RDR) Challenges Call.”
Read the full article here: https://www.chiesi.com/en/fostering-innovation-for-rare-diseases-in-europe-chiesi-supports-the-rdr-challenges-call/